Will Ozempic Help Lower Cholesterol?

Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist, was developed to help people manage blood sugar and lose weight—but emerging clinical data suggests it may also improve cholesterol profiles. Studies indicate that patients taking semaglutide often experience reductions in both LDL (bad) cholesterol and triglycerides, particularly when weight loss is achieved. PlexusDx offers personalized semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan, with precision genetic testing to identify which patients may respond best.

How Semaglutide Affects Cholesterol and Triglycerides

Semaglutide works by activating GLP-1 receptors in the brain and intestines, which slows digestion, reduces appetite, and improves blood sugar control. The primary cholesterol benefit comes indirectly: as patients lose weight, their bodies naturally produce less LDL cholesterol and their triglyceride levels drop. Research published in cardiovascular journals has shown that patients on semaglutide experienced average LDL reductions of 5–15% and triglyceride reductions of 10–25% over 6–12 months.

Weight loss itself is a powerful cholesterol-lowering mechanism. For every kilogram of body weight lost, LDL cholesterol typically decreases by approximately 0.5–1 mg/dL. Since semaglutide patients often achieve 5–15% body weight reduction, the cumulative effect on lipid profiles can be significant. This benefit is separate from any direct metabolic effects of the medication on liver cholesterol synthesis.

Clinical Evidence on Semaglutide and Cardiovascular Health

The SUSTAIN-6 trial, a landmark cardiovascular outcomes study, followed over 3,000 patients with type 2 diabetes taking semaglutide. Results showed a 26% reduction in major cardiovascular events compared to placebo, and notably, non-fatal heart attack risk dropped by 39%. While cholesterol reduction was not the primary endpoint, the overall cardiovascular benefit reflects improvements in multiple risk factors, including lipid panels, blood pressure, and inflammation markers.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding Your Individual Response With Genetic Testing

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predisposition to lipid dysfunction and medication response helps PlexusDx providers personalize your semaglutide dose and formulation. Patients with certain genetic profiles may achieve superior cholesterol reductions with compounded semaglutide injection compared to oral formulations, or may benefit from combination therapy approaches. This precision approach removes guesswork and optimizes outcomes.

Semaglutide vs. Statin Therapy: Are They Complementary?

Semaglutide is not a statin and should not be viewed as a cholesterol medication replacement. Rather, it addresses upstream metabolic drivers—weight, blood sugar control, inflammation—that contribute to abnormal cholesterol. Most cardiologists recommend continuing statins if you are already taking one, as statins work through a different mechanism (HMG-CoA reductase inhibition) and provide independent benefits. Combining semaglutide with statin therapy often produces better outcomes than either medication alone.

For patients who have not yet started a statin, semaglutide-induced weight loss and metabolic improvement may delay or reduce the need for statin therapy. However, this decision should always be made in consultation with a healthcare provider and based on your complete cardiovascular risk profile, family history, and lipid levels. PlexusDx recommends keeping your primary care doctor informed of all medication changes.

Getting Started With Personalized Semaglutide at PlexusDx

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and is dispensed from licensed 503A compounding pharmacies. The service is available across all 50 states with no insurance required and no membership fees. Your dose may increase as your body adjusts to the medication, but your monthly price will not change—PlexusDx's pricing model is flat per compound, regardless of dose level.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will semaglutide replace my cholesterol medication?

No, semaglutide is not a cholesterol-lowering drug like statins. Instead, it reduces cholesterol indirectly by promoting weight loss and improving metabolic health. Most patients continue statin therapy while taking semaglutide. Always consult your doctor before stopping any medication.

How much cholesterol reduction can I expect from semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does PlexusDx semaglutide work the same as brand-name Ozempic?

PlexusDx semaglutide is compounded from licensed 503A pharmacies and contains the same active ingredient as brand Ozempic. Compounded medications are not FDA-approved but are legal and regulated. Many patients find compounded options more affordable; semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) at PlexusDx.

Are there side effects that could affect my cholesterol levels?

Semaglutide's most common side effects are nausea, constipation, and diarrhea—typically mild and temporary. These do not directly harm cholesterol levels. Some patients experience pancreatitis (rare) or gallbladder issues; if you develop abdominal pain, inform your provider immediately. Overall, cardiovascular safety has been well-demonstrated in clinical trials.

What does the PlexusDx Precision Peptide Genetic Test reveal about cholesterol?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• How To Boost Hdl Cholesterol And Lower Heart Disease Risk
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.